Global pandemics, such as H1N1, are a major risk for neonatal patients. We surveyed U.K. tertiary and district neonatal units about visiting and infection control policies relating to viral respiratory infections. There was marked variation with visiting policies, tertiary units being more restrictive. Isolation, screening, and outbreak management of infected babies was highly variable posing a risk in future pandemics.
N ewborn infants, particularly preterm infants, are susceptible to nosocomial-acquired infections on the neonatal unit (NNU). The incidence of neonatal nosocomial viral respiratory tract infections (VRTIs) have probably been underestimated as viral investigations are not routinely obtained 1 due to their nonspecific clinical presentation and the lack of effective therapeutic interventions. 1 Approximately 3.8% of preterm infants < 31 weeks gestational age develop a symptomatic VRTI while on the NNU, but this can be as high as 52% when also screening asymptomatic infants. 2 VRTIs are now recognized to cause significant respiratory morbidity including increased requirement for home oxygen and are associated with increased healthcare utilization and cost of care. 2, 3 Children and adults can be asymptomatic carriers of respiratory viruses, 4 so when visiting the NNU may pose an infection risk to vulnerable infants particularly during global pandemics. 1, 2 There is lack of high-quality infection control or prevention studies aimed at reducing nosocomial VRTIs in the healthcare setting. 5 During the 2009-2011 H1N1 pandemic, we restricted visitors to our NNUs, only allowing parents to visit in most cases, with the aim of reducing the risk of infection. Despite this, we had five cases of H1N1 and two associated deaths. 2 In addition, we were anxious about the impact this may have on delivery of family-centered care. The aims of this study were to establish visiting policies and isolation practices in United Kingdom district local neonatal units (LNUs) and tertiary neonatal intensive care units (NICUs) when dealing with VRTI cases and potential future pandemics.
METHODS
We conducted a telephone and electronic structured survey (available on request) of visiting and infection control policies among U.K. neonatal services from August 2014 to January 2015. We contacted every LNU and NICU, seeking information on their visiting and infection control policies in the management of a baby with a VRTI. We focused on LNUs and NICUs as they care for the majority of high-risk newborns.
Data were analyzed with GraphPad Prism 7 (San Diego, CA). Comparisons were made between LNU and NICU using Fisher exact test. Statistical significance was considered at P < 0.05, and p-values were two-sided. This survey of current practice did not require ethical approval.
RESULTS
All 144 LNUs and NICUs listed on the Neonatal Data Analysis Unit in the United Kingdom were approached and all but one unit responded (99.3%), comprising 81 LNUs and 62 NICUs. Respondents were mostly the senior nurse-in-charge (n = 133).
Visiting Policy
More NICUs had a formal written visiting policy (n = 56, 91%) compared with LNUs (n = 54; 67%; P < 0.001). During the winter months, 21 units (15% of all respondents or 19% of those with a policy) changed their visiting policy.
Almost all units had an unrestricted visiting policy for parents (99%). Policies for visitors varied significantly with LNUs tending to operate a much less restrictive practice (see Table 1 ). LNUs allowed a greater number of visitors at the bedside with more than two visitors allowed in 49 (60%) LNUs versus 24 (38%) in NICUs.
Infection Control Policy
More LNUs tended to have separate rooms allowing isolation of infectious babies (89% versus 76%; P = 0.06). The majority (95%) of LNUs and NICUs isolate babies with VRTI although a variety of approaches are used (see Table 1 ).
A greater proportion of NICUs (70%) adopt a policy of screening other babies for VRTI compared with LNUs (53%) although this does not reach statistical significance. Once a baby has been diagnosed with a VRTI, then isolation of other babies in the same clinical area is highly variable with only 65% of units adopting this policy. Of respondents, only 55% knew they had a written policy for dealing with respiratory outbreaks.
DISCUSSION
There are few well-conducted studies exploring the potential impact that visiting and isolation policies have on nosocomial viral infections in NNUs. 5 The excellent response rate and good representation of U.K. NNUs suggest that this study accurately reflects practice and highlights the marked variation in visiting and infection control policies, perhaps reflecting the lack of evidence supporting different strategies.
Family-centered care is an important element of neonatal care, 6 and this is reflected in our data with 99% of NNUs adopting an unrestricted visiting policy for parents. However, greater restrictions are placed on other visitors and family members, which may have an impact on parental support networks, something the POPPY project found to be an important aspect of family-centered care. 7 The greater restrictions are perhaps due to concerns about the increased risk of infection and worries that NNU visits may be too traumatic, especially for younger children. 6 A similar European survey in 2005 found visiting policies, especially for siblings, relatives, and friends, more restrictive. 8 Only 35 U.K. NNUs participated in this survey with the majority allowing unrestricted parental access; however, up to 60% of these had restrictions including limited visit duration and restricting parents' presence during medical rounds. 8 The marked variation in policies we have highlighted can impact on family-centered care. Having a newborn admitted to the NNU can be extremely stressful for a parent, 7, 9 and while visits from relatives and friends may offer additional support to parents in such distressing times, one could argue that these could increase infection risk to the infants, especially if premature. Parents also find it stressful when moving between units to find differences in practice and policy, which may further compound their stress. 7 Despite the seasonal variation in certain viral respiratory illnesses, 4 the majority of neonatal services did not have a separate visiting policy during winter months and just over half have a written policy for dealing with outbreaks. This may suggest that U.K. NNUs are not prepared and may be less able to cope with large respiratory infection outbreaks especially during worldwide pandemics such as Influenza A (H1N1) where morbidity and mortality is high. This is reflected in the variation reported when dealing with nosocomial VRTIs on the NNU. The variance will impact on the barrier nursing precautions for staff and perhaps families. There is no clear evidence how long isolation should occur for in an infected baby as, despite being asymptomatic, they could still have evidence of viral genomic material in their secretions, 3 and it is unknown if this constitutes an infection risk to others.
There are potential cost considerations when performing culture or Polymerase Chain Reaction-based routine screening of other babies in the same clinical area when a baby is diagnosed with a nosocomial VRTI. This survey identified varied practice with this, which may represent a lack of evidence for this practice. Those units not screening could potentially delay the recognition of an outbreak and thus the steps to minimize this. Additional studies are required to identify the benefits of screening, the length of isolation, and when to stop testing in a previously symptomatic baby.
Given its nature as a national survey, the main limitation of our study is only one response per unit so these may not fully represent the actual policies of each unit although we did try to address R ates of indeterminate interferon-gamma release assay (IGRA) results in children being investigated for tuberculosis (TB) vary considerably, from as low as 0.6% up to 31%. [1] [2] [3] The clinical implications of an indeterminate IGRA result have not been well characterized. In our institution, indeterminate IGRA results are often associated with another underlying condition. We report an instance in which the finding of low mitogen responses in IGRA testing pointed to the underlying diagnosis.
CASE
A 13½-year-old Canadian-born boy presented with a 2-week history of neck pain and parasthesias and weakness in the upper limbs. Four months before, he had developed a cough and fever while visiting family in Jamaica. His symptoms continued despite treatment with oral antibiotics. Upon return to Toronto, he had a chest radiograph showing lobe airspace disease and a septated pleural effusion. There was no known contact with any individuals with TB. Cultures of sputum and pleural fluid were negative for mycobacteria, bacteria, fungi and other pathogens. The tuberculin skin test was negative with 0 mm of induration. He was treated with intravenous followed by oral cefuroxime and clindamycin. There was significant resolution of the airspace disease and partial resolution of the pleural effusion.
Examination revealed asymmetric weakness of the upper limbs more prominent on the right than the left and more proximal than distal, with absent reflexes. Magnetic resonance imaging of spine showed an extensive extramedullary collection extending from C1 to T8 with compression, distortion and displacement of the cord. He underwent cervical laminectomy and biopsy of an extradural mass. Histopathologic examination of the tissue showed evidence of noncaseating granulomata and no evidence of malignancy. Stains for acid-fast bacilli, fungi and bacteria were negative as were culture and polymerase chain reaction for TB and fungi. Microbiologic and molecular tests on pleural tissue were negative for TB, fungi, bacteria, viruses and Bartonella. The QuantiFERON-TB Gold In-Tube test (QFT-G-IT) was indeterminate with a mitogen-minus-nil interferon-gamma (IFN-γ) value of 0.22 IU/mL.
Based on clinical presentation including pleural and pulmonary disease, he was treated for possible TB disease with isoniazid, rifampin, pyrazinamide and ethambutol as well as dexamethasone for cord compression.
Upon discharge, he had a full range of neck movement and a near-normal power of his upper limbs. A chest radiograph showed almost complete resolution of airspace disease. However, his clinical course was marked by recurrence of clinical and imaging abnormalities whenever dexamethasone was weaned and the indeterminate QFT test led clinicians to further investigations. Genetic testing identified the presence of NOD2/CARD15 gene mutation, confirming the diagnosis of sarcoidosis. He was treated The rate of low-mitogen indeterminate interferon-gamma release assay results at a hospital with expert pediatric phlebotomy and rapid incubation of specimens was 0.96%. All low-mitogen indeterminate results were found to be associated with an immunocompromised or anergic state. We describe a child where an unexpected indeterminate interferon-gamma release assay test pointed to an underlying anergic condition and was of diagnostic significance.
OPTIMIZING BLOOD COLLECTION AND PROCESSING FOR QUANTIFERON-TB GOLD IN-TUBE TESTING GIVES LOW RATES OF INDETERMINATE RESULTS: CLINICAL IMPLICATIONS
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Accepted for publication July 9, 2017. this by contacting senior staff. Also, some NNUs may have revised their visiting and infection control policies since the period of data collection. As VRTIs are now increasingly recognized as an important cause of respiratory morbidity and associated healthcare costs, we need to develop an evidence base behind these policies and consider national guidance that could help reduce this burden and ensure we are prepared for future worldwide pandemics while maintaining family-centered care.
